[go: up one dir, main page]

SE9904863D0 - New use - Google Patents

New use

Info

Publication number
SE9904863D0
SE9904863D0 SE9904863A SE9904863A SE9904863D0 SE 9904863 D0 SE9904863 D0 SE 9904863D0 SE 9904863 A SE9904863 A SE 9904863A SE 9904863 A SE9904863 A SE 9904863A SE 9904863 D0 SE9904863 D0 SE 9904863D0
Authority
SE
Sweden
Prior art keywords
drug
growth factor
new use
nerve growth
administrated
Prior art date
Application number
SE9904863A
Other languages
Swedish (sv)
Inventor
Thomas Lundeberg
Original Assignee
Medscand Medical Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medscand Medical Ab filed Critical Medscand Medical Ab
Priority to SE9904863A priority Critical patent/SE9904863D0/en
Publication of SE9904863D0 publication Critical patent/SE9904863D0/en
Priority to AU27198/01A priority patent/AU2719801A/en
Priority to PCT/SE2000/002698 priority patent/WO2001049313A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Psychology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Neurology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention relates to the use of nerve growth factor for the manufacturing of a drug for treating allergic disorders in human beings and animals. Preferably, the drug is administrated to the site of action at a nerve growth factor concentration which does not result in the perception of pain.
SE9904863A 1999-12-30 1999-12-30 New use SE9904863D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE9904863A SE9904863D0 (en) 1999-12-30 1999-12-30 New use
AU27198/01A AU2719801A (en) 1999-12-30 2000-12-29 Use of ngf for the manufacturing of a drug for treating allergic disorders
PCT/SE2000/002698 WO2001049313A1 (en) 1999-12-30 2000-12-29 Use of ngf for the manufacturing of a drug for treating allergic disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9904863A SE9904863D0 (en) 1999-12-30 1999-12-30 New use

Publications (1)

Publication Number Publication Date
SE9904863D0 true SE9904863D0 (en) 1999-12-30

Family

ID=20418378

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9904863A SE9904863D0 (en) 1999-12-30 1999-12-30 New use

Country Status (3)

Country Link
AU (1) AU2719801A (en)
SE (1) SE9904863D0 (en)
WO (1) WO2001049313A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2004118424A (en) * 2001-11-19 2005-05-10 Новартис АГ (CH) APPLICATION OF ASKOMICIN FOR THE TREATMENT OF BLEFARIT
DK1891966T3 (en) 2002-12-20 2012-04-02 Lundbeck & Co As H Modulation of neurotrophin activity; method of screening
PL3225251T3 (en) 2006-12-21 2020-06-29 H. Lundbeck A/S Modulation of activity of proneurotrophins
CN101951943A (en) * 2007-12-20 2011-01-19 赛托斯生物技术公司 NGF conjugates and uses thereof
AU2013207346A1 (en) * 2012-01-05 2014-06-05 Beech Tree Labs, Inc. Method of treating pain by administration of Nerve Growth Factor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07242564A (en) * 1994-03-02 1995-09-19 Sagami Chem Res Center Bone formation accelerator
AU7214998A (en) * 1997-04-11 1998-11-11 Regents Of The University Of California, The Ngf for the prevention of demyelination in the nervous system
CA2792479A1 (en) * 1998-02-27 1999-09-02 The Trustees Of The University Of Pennsylvania Vaccines, immunotherapeutics and methods for using the same

Also Published As

Publication number Publication date
AU2719801A (en) 2001-07-16
WO2001049313A1 (en) 2001-07-12

Similar Documents

Publication Publication Date Title
EP1605956A4 (en) Administration of capsaicinoids
DE60322436D1 (en) ADMINISTRATION OF CAPSAICINOIDS
NO20101190L (en) Use of buprenorphine in the manufacture of a medicament
ATE429922T1 (en) TOPICAL GEL DELIVERY SYSTEMS FOR THE TREATMENT OF SKIN DISEASES
ATE399553T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING DEXTROMETHORPHAN AND QUINIDENE FOR THE TREATMENT OF NEUROLOGICAL DISEASES
ATE355374T1 (en) THERAPEUTIC AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF AMYLOIDOGENIC DISEASES
DE69230046D1 (en) 2-bromomelatonin for the treatment of sleep disorders
EA200701131A1 (en) PREPARATIVE FORM OF CAPSAICINOIDE AND METHODS OF ITS APPLICATION
DE59911740D1 (en) TOPIC APPLICABLE AGENTS AGAINST NAIL MUSHROOM DISEASES
DE69017654D1 (en) ANALGETIC LOTION TO BE APPLIED ON THE OUTSIDE AND METHOD FOR THE PRODUCTION THEREOF.
CY1106155T1 (en) USE OF 3-BENZOPHENYLACETIC ACID DERIVATIVES FOR THE TREATMENT OF AMPHIBLISTROID DISORDERS
DE69621243D1 (en) USE OF BRADYKININE ANTAGONISTS FOR INDUCING OR STIMULATING HAIR GROWTH AND / OR FOR SLOWING HAIR LOSS
ATE222101T1 (en) USE OF SELEGILINE OR DESMETHYLSELEGILINE TO TREAT WOUNDS, BURNS, AND SKIN DAMAGE
DK1343472T3 (en) Thixotropic nasal spray
SE9904863D0 (en) New use
TW200501934A (en) Therapeutic causing contraction of mucosal tissue, method of treating diseases relating to mucosal tissues, injector and therapeutic set
DE69822276T2 (en) HERBAL FORMULATION WITH THERAPEUTIC AND COSMETIC USE FOR THE TREATMENT OF GENERAL SKIN DISEASES
DE60213234D1 (en) 4- (PENYLPIPERIDIN-4-YLIDENETHYL) BENZAMID DERIVATIVES AND THEIR USE FOR THE TREATMENT OF PAIN, FEAR STORIES OR DISEASES OF THE STOMACH DARM TRAKTS
ATE297739T1 (en) ENDOTHELIN ANTAGONISTS FOR THE TREATMENT OF HEART FAILURE
ATE316379T1 (en) OXYHUMIC ACID AND ITS USE IN THE TREATMENT OF VARIOUS DISORDERS
ATE373482T1 (en) PHARMACEUTICAL COMPOSITION FOR THE TOPICAL TREATMENT OF SKIN DISEASES AND SKIN WOUNDS
US9775995B2 (en) Treating skin ulcers
DE69900774D1 (en) USE OF TOPICAL PREPARATIONS WITH GLYCERYL TRINITRATE AND LANOLIN FOR TREATING ERECTILE FUNCTIONAL DISORDERS
ATE369143T1 (en) USE OF NGALI NUT OIL TO TREAT/RELIEF ARTHRITIS PAIN AND OTHER SIMILAR DISORDERS
ATE358490T1 (en) USE OF A COMBINATION OF A PURINE AND A NO-DONOR FOR THE TREATMENT AND PROPHYLAXIS OF SEXUAL FUNCTION DISORDERS